Rchr
J-GLOBAL ID:202001012074301805
Update date: Apr. 28, 2024
Ohmoto Akihiro
オオモト アキヒロ | Ohmoto Akihiro
Affiliation and department:
Research field (3):
Tumor biology
, Genomics
, Hematology and oncology
Research keywords (1):
希少がん、神経内分泌腫瘍、肉腫、頭頸部がん、悪性リンパ腫
Research theme for competitive and other funds (6):
Papers (67):
-
Naomi Hayashi, Seiichi Mori, Akihiro Ohmoto, Ippei Fukada, Masumi Yamazaki, Mari Hosonaga, Xiaofei Wang, Arisa Ueki, Kazuma Kiyotani, Akiko Tonooka, et al. Availability of genome-matched therapy based on clinical practice. International journal of clinical oncology. 2024
-
Akihiro Ohmoto, Shigeo Fuji. Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy. 2024. 1-10
-
Akihiro Ohmoto, Naomi Hayashi, Shunji Takahashi, Arisa Ueki. Current prospects of hereditary adrenal tumors: towards better clinical management. Hereditary cancer in clinical practice. 2024. 22. 1. 4-4
-
Akihiro Ohmoto, Shigeo Fuji. Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert Review of Anti-infective Therapy. 2024. 1-10
-
Akihiro Ohmoto, Shigeo Fuji. Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen. Expert review of hematology. 2023
more...
MISC (14):
-
Course for Medical Oncologist : Prep test for medical oncologist(115)answer and explanation. 2019. 24. 5. 517-520
-
大本 晃弘, 森実 千種. 【膵癌・胆道癌最新動向-変わる!膵癌周術期化学療法と免疫チェックポイント阻害剤-】膵癌・胆道癌の遺伝子的・免疫的特徴 家族性膵癌における遺伝子変異. 肝・胆・膵. 2019. 78. 5. 765-771
-
大本 晃弘, 森実 千種. 【膵胆道腫瘍におけるゲノム医療の現状と展望】膵神経内分泌腫瘍のゲノミクス. 胆と膵. 2019. 40. 4. 327-332
-
大本 晃弘. 改訂ベセスダ基準に該当する既往歴・家族歴を有する膵がん患者における生殖細胞系列変異に関する研究. 日本膵臓病研究財団研究報告書. 2018. 25回. 63-67
-
大本 晃弘, 藤 重夫, 前島 亜希子, 金 成元, 田島 絹子, 田中 喬, 冲中 敬二, 黒澤 彩子, 稲本 賢弘, 谷口 浩和, et al. 移植前鉄過剰のフェリチンおよび病理学的評価と予後に与える影響に関する検討. Biomedical Research on Trace Elements. 2016. 27. 2. 85-85
more...
Professional career (2):
Return to Previous Page